Techno Venture Management logo

Techno Venture Management

North America, Massachusetts, United States, Boston

Description

Techno Venture Management, widely recognized as TVM Capital, is a prominent venture capital and private equity firm with a dedicated focus on the healthcare industry. While the firm operates globally, its presence in Boston, United States, aligns with its significant activities in North American life sciences. Established in 1984, TVM Capital has built a long-standing reputation for identifying and nurturing innovative companies across the biotech, pharmaceutical, medical device, and digital health sectors.

The firm's investment strategy centers on early to mid-stage companies that possess disruptive technologies or therapies with the potential to address significant unmet medical needs. TVM Capital typically seeks out opportunities where its deep industry expertise and extensive network can add substantial value beyond just capital. They often engage in a hands-on approach, collaborating closely with management teams to navigate complex development pathways, regulatory hurdles, and market entry strategies.

TVM Capital has demonstrated substantial scale and impact within the healthcare investment landscape. Across its various funds, TVM Capital Life Science alone has successfully raised over $1.8 billion in capital since its inception. This capital has been strategically deployed to support the growth of a diverse portfolio, with the firm having invested in over 140 companies across North America and Europe. Their commitment to fostering innovation and driving advancements in healthcare solidifies their position as a key player in the venture capital ecosystem.

Investor Profile

Techno Venture Management has backed more than 98 startups, with 0 new investments in the last 12 months alone. The firm has led 20 rounds, about 20% of its total and boasts 37 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series B, Series A rounds (top funding stages).
  • Majority of deals are located in United States, Germany, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Typical check size: $3M – $15M.

Stage Focus

  • Series Unknown (38%)
  • Series B (21%)
  • Series A (15%)
  • Series C (10%)
  • Seed (4%)
  • Series D (3%)
  • Series E (2%)
  • Post Ipo Equity (2%)
  • Undisclosed (1%)
  • Private Equity (1%)

Country Focus

  • United States (55%)
  • Germany (27%)
  • United Kingdom (7%)
  • Switzerland (4%)
  • Austria (2%)
  • The Netherlands (2%)
  • France (1%)
  • Israel (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Software
  • Information Technology
  • Therapeutics
  • Health Diagnostics
  • Manufacturing
  • Network Hardware
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Techno Venture Management frequently co-invest with?

Birchmere Ventures
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 3
Star Ventures
Europe, Bayern, Germany, München
Co-Investments: 4
Adams Capital Management
North America, Pennsylvania, United States, Sewickley
Co-Investments: 3
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 4
AlpInvest Partners
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 6
Austin Ventures
North America, Texas, United States, Austin
Co-Investments: 3
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 3
Oxford Bioscience Partners
North America, Massachusetts, United States, Boston
Co-Investments: 5
Sofinnova Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 4
Draper Triangle
North America, Pennsylvania, United States, Pittsburgh
Co-Investments: 4

What are some of recent deals done by Techno Venture Management?

Helomics

Pittsburgh, Pennsylvania, United States

Helomics provides comprehensive tumor profiling utilizing proprietary tissue-based live cell and fixed cell products and services.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Series UnknownNov 11, 2008
Amount Raised: $43,000,000
Precision Therapeutics

Pittsburgh, Pennsylvania, United States

Precision Therapeutics is a pharmaceutical research and development business that develops personalized cancer treatments for patients.

Clinical TrialsHealth CarePersonal HealthPharmaceutical
Series BFeb 22, 2006
Amount Raised: $20,000,000
Streaming21

Los Gatos, California, United States

Streaming21 is a solution provider of seamless on-demand and IP broadcasting service platform for connected digital home.

BroadcastingSoftwareVideo
Series UnknownAug 16, 2005
Revolt Technology

Portland, Oregon, United States

ReVolt Technology is a technology company developing rechargeable zinc-air batteries.

Energy StorageHardwareSoftware
Series AJun 28, 2005
Amount Raised: $8,453,963
VPIsystems

Somerset, New Jersey, United States

VPIsystems develops and markets network planning software and services for the telecommunications industry.

Consumer SoftwareSoftwareTelecommunicationsWireless
Series UnknownMar 1, 2005
Amount Raised: $9,000,000
Bluebird Bio

Somerville, Massachusetts, United States

Bluebird Bio is a biopharma company that develops and commercializes gene therapies for the treatment of severe genetic diseases and cancer.

BiotechnologyGeneticsHealth DiagnosticsOncologyPharmaceutical
Series UnknownOct 7, 2004
Amount Raised: $12,000,000
iTAC Software

Dernbach, Hessen, Germany

ITAC Software provides and develops manufacturing executing systems and solutions to the manufacturing industry.

ManufacturingSoftware
Series COct 6, 2004
Amount Raised: $5,527,414
Coley Pharmaceutical Group

Wellesley, Massachusetts, United States

Coley Pharmaceutical Group develops therapeutics and drug candidates to fight cancers, asthma, allergy and autoimmune disorders.

BiotechnologyHealth CareMedical
Series GSep 14, 2004
Amount Raised: $25,200,000
Enanta Pharmaceuticals

Watertown, Massachusetts, United States

Enanta Pharmaceuticals is an R&D company discovers, develops and promotes of small molecule drugs in the areas of anti-infective.

BiotechnologyHealth CarePharmaceutical
Series UnknownAug 31, 2004
Amount Raised: $20,000,000
Infitel International

Nieuwegein, Utrecht, The Netherlands

Infitel International is a provider of solutions for telecommunications value-added services based on intelligent networks (IN platforms).

Communication HardwareNetwork Hardware
Series UnknownAug 16, 2004
Amount Raised: $7,406,776